Marksans Pharma LimitedNSE: MARKSANS

Press Release Nov 06 2023

· Issued by Marksans Pharma Limited

Filed with NSE ·

Marksans Pharma Limited has informed the Exchange regarding a press release dated November 06, 2023, titled "Marksans Pharma Limited's wholly owned subsidiary Relonchem Limited, receives Marketing Authorisation for the product Cyanocobalamin 50mg film coated tablets".

View Attachment

6ix hasn’t read this filing yet.

Marksans Pharma Limited on 6ix

In the deck

Earlier from Marksans Pharma

Later from Marksans Pharma

All Marksans Pharma news releases